Stockscreener 앱 받기
6.27
0.32%
-0.02
시간 외 거래:
6.32
0.05
+0.80%
Minerva Neurosciences Inc 주식(NERV)의 최신 뉴스
Minerva Neurosciences (NASDAQ:NERV) Stock Price Passes Above 50-Day Moving AverageWhat's Next? - MarketBeat
Minerva Neurosciences Expands Board Amid Fundraising Effort - MSN
Market Wrap: Can Minerva Neurosciences Inc continue delivering strong returnsLayoff News & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Minerva Neurosciences Inc (NERV) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Analysts Have Conflicting Sentiments on These Healthcare Companies: Minerva Neurosciences (NERV) and Verastem (VSTM) - The Globe and Mail
Analysts Have Conflicting Sentiments on These Healthcare Companies: Minerva Neurosciences (NERV), Gossamer Bio (GOSS) and Merck & Company (MRK) - The Globe and Mail
Minerva Neurosciences Spotlights Roluperidone, Lays Out Confirmatory Phase 3 Timeline for Schizophrenia - MarketBeat
Minerva Outlines Confirmatory Phase 3 Plan for Roluperidone - TipRanks
Buyout Rumor: Is Minerva Neurosciences Inc subject to activist investor interest2025 Trading Recap & Real-Time Stock Entry Alerts - baoquankhu1.vn
Is Minerva Neurosciences Inc. subject to activist investor interestRate Cut & Reliable Momentum Entry Alerts - mfd.ru
Stock Analysis: Can Minerva Neurosciences Inc be recession proofJuly 2025 Setups & Momentum Based Trading Ideas - baoquankhu1.vn
Can Minerva Neurosciences Inc. stock double in the next yearJuly 2025 PreEarnings & Community Consensus Picks - mfd.ru
Minerva Neurosciences (NASDAQ:NERV) Share Price Passes Above 50-Day Moving AverageTime to Sell? - MarketBeat
Can Minerva Neurosciences Inc. stock outperform in a bear marketJuly 2025 Weekly Recap & Weekly Top Performers Watchlists - mfd.ru
Minerva Neurosciences to Host Virtual KOL Event to Discuss - GlobeNewswire
Minerva to spotlight potential first drug for key schizophrenia symptoms - Stock Titan
Highs Report: Is Minerva Neurosciences Inc trading at a discountJuly 2025 Price Swings & Fast Moving Market Watchlists - baoquankhu1.vn
Minerva Neurosciences (NASDAQ:NERV) Share Price Passes Above 50 Day Moving AverageWhat's Next? - MarketBeat
Earnings Update: Can Minerva Neurosciences Inc stock double in the next yearFed Meeting & Free Long-Term Investment Growth Plans - baoquankhu1.vn
FOMO Trade: Will Minerva Neurosciences Inc benefit from seasonalityJuly 2025 Movers & Precise Entry and Exit Recommendations - baoquankhu1.vn
Downgrade Watch: Can Minerva Neurosciences Inc stock reach 100 price targetWeekly Investment Summary & Stepwise Trade Signal Guides - Bộ Nội Vụ
Gap Down: Will Minerva Neurosciences Inc 4MNA stock top growth indexes - Bộ Nội Vụ
Street Watch: Is Minerva Neurosciences Inc stock a top pick in earnings seasonVolume Spike & Real-Time Stock Movement Alerts - Bộ Nội Vụ
Wall Street Recap: Why analysts upgrade Minerva Neurosciences Inc. stock2025 Key Highlights & Verified Short-Term Trading Plans - Bộ Nội Vụ
Minerva Neurosciences (NASDAQ:NERV) Cut to Sell at Wall Street Zen - MarketBeat
What risks investors should watch in Minerva Neurosciences Inc. stockWeekly Profit Analysis & Consistent Profit Trade Alerts - Улправда
Is Minerva Neurosciences Inc. (4MNA) stock attractive for dividend growth2025 Trading Volume Trends & Long-Term Capital Growth Strategies - Улправда
Is Minerva Neurosciences Inc. stock attractive for hedge fundsJuly 2025 Technicals & Real-Time Buy Signal Notifications - Улправда
Why Minerva Neurosciences Inc. stock is in analyst buy zone2025 Analyst Calls & Long-Term Investment Growth Plans - Улправда
Is Minerva Neurosciences Inc. stock safe for conservative investorsJuly 2025 Retail & Reliable Trade Execution Plans - Улправда
Why Minerva Neurosciences Inc. stock is rated strong buyJuly 2025 Momentum & Consistent Return Investment Signals - Улправда
Will Minerva Neurosciences Inc. (4MNA) stock top growth indexes2025 Momentum Check & Reliable Momentum Entry Alerts - Улправда
Minerva Neurosciences (NASDAQ:NERV) Upgraded to "Hold" at Wall Street Zen - MarketBeat
Minerva Neurosciences (NASDAQ:NERV) & UCB (OTCMKTS:UCBJY) Head to Head Analysis - Defense World
Working capital per share of Minerva Neurosciences Inc – MUN:4MNA - TradingView — Track All Markets
Gains Recap: Why Minerva Neurosciences Inc stock is in analyst buy zoneProduct Launch & Free Expert Verified Stock Movement Alerts - moha.gov.vn
MSN Money - MSN
Published on: 2025-12-26 01:20:46 - moha.gov.vn
Reviewing Xenetic Biosciences (NASDAQ:XBIO) and Minerva Neurosciences (NASDAQ:NERV) - Defense World
Minerva Neurosciences shareholders approve key governance measures - MSN
Minerva Neurosciences Shareholders Approve Key Governance Measures - TipRanks
Risks Report: Why Minerva Neurosciences Inc. (4MNA) stock stays resilientMarket Activity Summary & Free High Accuracy Swing Entry Alerts - Улправда
Movement Recap: Why analysts upgrade Minerva Neurosciences Inc. stock2025 Growth vs Value & AI Powered Market Entry Ideas - Улправда
How strong is Minerva Neurosciences Inc. stock revenue growthGold Moves & Weekly High Return Forecasts - Улправда
Why analysts upgrade Minerva Neurosciences Inc. stockIndex Update & Risk Controlled Swing Alerts - Улправда
1.12%
0.87%
자본화:
|
볼륨(24시간):